Literature DB >> 16100146

Obstructive sleep apnea syndrome in morbid obesity: effects of intragastric balloon.

Luca Busetto1, Giuliano Enzi, Emine Meral Inelmen, Gabriella Costa, Valentina Negrin, Giuseppe Sergi, Andrea Vianello.   

Abstract

STUDY
OBJECTIVES: In obese patients, obstructive sleep apnea syndrome (OSAS) is attributed to a reduction in pharyngeal cross-sectional area due to peripharyngeal fat deposition. The effect of weight loss on the size of the upper airways of obese subjects is still unknown. We analyzed the pharyngeal cross-sectional area before and after weight loss in morbidly obese patients with OSAS. DESIGN, SETTING, AND
SUBJECTS: A group of 17 middle-aged, morbidly obese men was evaluated by anthropometry and cardiorespiratory sleep studies before and after weight loss obtained by insertion of an intragastric balloon. The pharyngeal cross-sectional area was measured by acoustic pharyngometry.
RESULTS: The mean (+/- SD) body mass index was 55.8 +/- 9.9 kg/m2 at baseline and 48.6 +/- 11.2 kg/m2 at the time of balloon removal (6 months after insertion) [p < 0.001]. At baseline, patients had visceral obesity, large necks, and severe OSAS. Weight loss was associated with a significant mean reduction of waist circumference (156.4 +/- 17.6 vs 136.7 +/- 18.4 cm, respectively; p < 0.001), sagittal abdominal diameter (37.8 +/- 3.0 vs 32.3 +/- 4.0 cm, respectively; p < 0.001), and neck circumference (51.1 +/- 3.7 vs 47.9 +/- 4.3 cm, respectively; p < 0.001). Moreover, weight loss induced a nearly complete resolution of OSAS (apnea-hypopnea index, 52.1 +/- 14.9 vs 14.0 +/- 12.4 events/h, respectively; p < 0.001). At baseline, obese patients had significantly lower pharyngeal cross-sectional areas compared to a group of 20 nonobese male control subjects, both in the upright and supine position, at different levels of the pharynx. In obese patients, the weight loss induced by the positioning of the intragastric balloon was associated with an increase in the size of the upper airway passage. After weight loss, both the mean pharyngeal cross-sectional area and the area at glottis level were still lower in obese subjects than in nonobese subjects; however, the pharyngeal cross-sectional area at the oropharyngeal junction was similar in the two groups.
CONCLUSIONS: Morbidly obese men with OSAS have a reduced pharyngeal cross-sectional area. A weight reduction of about 15% of baseline body weight may substantially increase the pharyngeal cross-sectional area and substantially improve the severity of OSAS in morbidly obese subjects with sleep apnea.

Entities:  

Mesh:

Year:  2005        PMID: 16100146     DOI: 10.1378/chest.128.2.618

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  36 in total

1.  Is obesity a prognostic factor for acute myeloid leukemia outcome?

Authors:  Hun Ju Lee; Andrea S Licht; Andrew J Hyland; Laurie A Ford; Sheila N J Sait; Annemarie W Block; Maurice Barcos; Maria R Baer; Eunice S Wang; Meir Wetzler
Journal:  Ann Hematol       Date:  2011-09-21       Impact factor: 3.673

Review 2.  [Comorbidities and complications of adiposis].

Authors:  C Dieterle; R Landgraf
Journal:  Internist (Berl)       Date:  2006-02       Impact factor: 0.743

3.  Upper airway size is related to obesity and body fat distribution in women.

Authors:  Luca Busetto; Elisa Calo'; Marco Mazza; Fabio De Stefano; Gabriella Costa; Valentina Negrin; Giuliano Enzi
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-07-29       Impact factor: 2.503

4.  Dual-energy X-ray absorptiometry analysis of body composition in patients affected by OSAS.

Authors:  Ernesto Bruno; Marco Alessandrini; Bianca Napolitano; Alessandro De Padova; Nicola Di Daniele; Antonino De Lorenzo
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-11-04       Impact factor: 2.503

5.  Neck Circumference and Vocal Parameters in Women Before and After Bariatric Surgery.

Authors:  Lourdes Bernadete Rocha de Souza; Leandro de Araújo Pernambuco; Marquiony Marques dos Santos; Rayane Medeiros Pereira
Journal:  Obes Surg       Date:  2016-03       Impact factor: 4.129

Review 6.  Evidence-based review of the Bioenterics intragastric balloon for weight loss.

Authors:  Jean-Marc Dumonceau
Journal:  Obes Surg       Date:  2008-06-21       Impact factor: 4.129

7.  [Guideline: Treatment of obstructive sleep apnea in adults].

Authors:  T Verse; R Bodlaj; R de la Chaux; A Dreher; C Heiser; M Herzog; W Hohenhorst; K Hörmann; O Kaschke; T Kühnel; N Mahl; J T Maurer; W Pirsig; K Rohde; A Sauter; M Schedler; R Siegert; A Steffen; B A Stuck
Journal:  HNO       Date:  2009-11       Impact factor: 1.284

Review 8.  Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis.

Authors:  Iñaki Imaz; Carmen Martínez-Cervell; Elvira Elena García-Alvarez; Juan Manuel Sendra-Gutiérrez; Jesús González-Enríquez
Journal:  Obes Surg       Date:  2008-05-06       Impact factor: 4.129

9.  Cardiorespiratory phase-coupling is reduced in patients with obstructive sleep apnea.

Authors:  Muammar M Kabir; Hany Dimitri; Prashanthan Sanders; Ral Antic; Eugene Nalivaiko; Derek Abbott; Mathias Baumert
Journal:  PLoS One       Date:  2010-05-13       Impact factor: 3.240

10.  Efficacy of a conservative weight loss program in the long-term management of chronic upper airway obstruction.

Authors:  Ryan C Case; John Schweinfurth
Journal:  Int J Otolaryngol       Date:  2009-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.